Federated Hermes’s Alterity Therapeutics ATHE Stock Holding History

Federated Hermes’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-667	Closed	-$164K	–	1757
2013 Q3	$164K	Buy	+667	New	+$153K	﹤0.01%	1495

Other funds holding ATHE

GBA

Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CAM

Columbia Asset Management Ann Arbor, Michigan $575M AUM 29.81% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Federated Hermes's ATHE Position: Q4 2013 in Review

Federated Hermes sold out of Alterity Therapeutics (ATHE) in Q4 2013, closing a stake of 667 shares — an estimated $164K sold.

Federated Hermes first reported a position in ATHE in Q3 2013 and held it in 1 quarter. The position peaked at $164K in Q3 2013. 23 funds tracked by Wall St. Rank hold ATHE as of Q4 2013.

Federated Hermes reported no remaining Alterity Therapeutics position as of Q4 2013 after selling out during the quarter.
Federated Hermes sold 667 Alterity Therapeutics shares in Q4 2013, an estimated $164K.
Federated Hermes first reported a position in Alterity Therapeutics in Q3 2013 and held it in 1 quarter.
Federated Hermes's Alterity Therapeutics position peaked at $164K in Q3 2013.
23 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2013.

Based on Federated Hermes's 13F filing for Q4 2013, filed 11 Feb 2014.